Scholarlink

Background <p>This cross-sectional controlled study aims to characterize ocular manifestations and corneal microstructure via in vivo confocal microscopy (IVCM) in mainland Chinese patients with Fabry disease (FD). We evaluated 30 FD patients (mean age: 38 ± 14.41 years; range: 10–60 years), divided equally into enzyme replacement therapy (ERT)-treated and untreated groups, alongside 30 age- and gender-matched healthy controls. Slit-lamp examinations assessed ocular manifestations, while IVCM was employed to analyze corneal microstructure.</p> Results <p>Eighteen FD patients presented with corneal verticillata (CV) opacities. High-reflective intracellular inclusions were identified in the corneal basal epithelial cells in the majority of FD patients (22 out of 30). IVCM detected increased dendritic cells (DCs) in three FD patients. The nerve fiber layer showed an increased corneal nerve tortuosity coefficient (<i>P</i> &lt; 0.001), decreased nerve fiber density (NFD) (<i>P</i> = 0.033), decreased nerve fiber length (NFL) (<i>P</i> = 0.012), and reduced fractal dimension (<i>P</i> = 0.010) in FD patients compared to healthy controls. Reduced transparency of the anterior corneal stroma and the presence of visible microdots were observed in 11 out of 30 FD patients. Endothelial morphological parameters in FD patients showed no obvious differences compared to healthy controls. α-galactosidase A (α-Gal A) activity was negatively correlated with Mainz Severity Score Index (MSSI) scores (<i>P</i> = 0.001), whereas plasma globotriaosylsphingosine (lyso-Gb3) levels and posterior capsular opacification exhibited a direct correlation with MSSI scores(<i>P</i> = 0.002). None of these changes showed significant differences in FD patients, regardless of ERT.</p> Conclusions <p>This study substantially enhances our understanding of FD-associated ocular alterations in the mainland Chinese demographic. The presence of CV opacities, posterior capsular opacification, or distinct changes observed in IVCM offers the potential for early detection of FD. Additionally, there is a notable increase in DCs and a positive correlation between posterior capsular opacification and MSSI scores. These findings support the integration of ocular biomarker screening into standardized FD diagnostic protocols to facilitate pre-symptomatic interventions, particularly in familial risk cohorts.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ocular and confocal manifestations of Mainland Chinese with Fabry disease: a cross-sectional controlled study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月10日

查看全文
  • Yao Xu,
  • Yingjie Chen,
  • Jiali Fan,
  • Sasa Kou,
  • Xinyu Zhuang,
  • Bingyuan Zhou,
  • Xiaofeng Zhang

摘要

Background

This cross-sectional controlled study aims to characterize ocular manifestations and corneal microstructure via in vivo confocal microscopy (IVCM) in mainland Chinese patients with Fabry disease (FD). We evaluated 30 FD patients (mean age: 38 ± 14.41 years; range: 10–60 years), divided equally into enzyme replacement therapy (ERT)-treated and untreated groups, alongside 30 age- and gender-matched healthy controls. Slit-lamp examinations assessed ocular manifestations, while IVCM was employed to analyze corneal microstructure.

Results

Eighteen FD patients presented with corneal verticillata (CV) opacities. High-reflective intracellular inclusions were identified in the corneal basal epithelial cells in the majority of FD patients (22 out of 30). IVCM detected increased dendritic cells (DCs) in three FD patients. The nerve fiber layer showed an increased corneal nerve tortuosity coefficient (P < 0.001), decreased nerve fiber density (NFD) (P = 0.033), decreased nerve fiber length (NFL) (P = 0.012), and reduced fractal dimension (P = 0.010) in FD patients compared to healthy controls. Reduced transparency of the anterior corneal stroma and the presence of visible microdots were observed in 11 out of 30 FD patients. Endothelial morphological parameters in FD patients showed no obvious differences compared to healthy controls. α-galactosidase A (α-Gal A) activity was negatively correlated with Mainz Severity Score Index (MSSI) scores (P = 0.001), whereas plasma globotriaosylsphingosine (lyso-Gb3) levels and posterior capsular opacification exhibited a direct correlation with MSSI scores(P = 0.002). None of these changes showed significant differences in FD patients, regardless of ERT.

Conclusions

This study substantially enhances our understanding of FD-associated ocular alterations in the mainland Chinese demographic. The presence of CV opacities, posterior capsular opacification, or distinct changes observed in IVCM offers the potential for early detection of FD. Additionally, there is a notable increase in DCs and a positive correlation between posterior capsular opacification and MSSI scores. These findings support the integration of ocular biomarker screening into standardized FD diagnostic protocols to facilitate pre-symptomatic interventions, particularly in familial risk cohorts.